Intrinsic Value

Is DGNMF undervalued or overvalued?

See the intrinsic value estimate for DiagnaMed Holdings Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

DGNMF Intrinsic Value
LOCKED
Unlock
Today vs. history

DGNMF looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with DGNMF’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor DGNMF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price $0.02
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to DGNMF

Fundamental Analysis

What DiagnaMed Does

DiagnaMed Holdings Corp. is a biotechnology company, which engages in the development and commercialization of digital therapeutics for mental health and neurological disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm is developing a platform of software-based prescription digital therapeutic products (PDT Products) for detecting brain age and tremors for neurological disorders.

Headquarters
Canada CA
IPO date
Nov 8, 2022
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
DiagnaMed Holdings Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one DGNMF stock?

The intrinsic value for DiagnaMed Holdings Corp (DGNMF) under the Base Case is hidden USD.

Is DGNMF stock undervalued or overvalued?

Compared with the current market price of 0.0214 USD, the stock appears hidden.

Back to Top